A placebo-controlled study of the results are equally unknown both testers and the tested (double-blind) of 494 children showed that supplementation of Lactobacillus reuteri Protectis substantially reduces the incidence of diarrhea. Lactobacillus reuteri Protectis especially effective in children with low nutritional status. Other types of probiotics, which was also tested, with no effect.
The design of the study
A double-blind placebo-controlled for six months was conducted in Indonesia and included 494 healthy children aged one to six years. These children were randomly assigned to low-lactose milk with or without Lactobacillus casei or Lactobacillus reuteri DSM17938 431.
The main result is the amount and duration of acute diarrheal disease. Diarrhea is measured based on information from the World Health Organization (WHO), is greater than or equal to 3 loose / liquid stools within 24 hours, and as all diarrheal disease, greater than or equal to 2 loose / liquid stools in 24 hours. Secondary outcomes were the number and duration of acute respiratory infection.
The results were significant only with Lactobacillus reuteri Protectis
The results showed that the incidence of all diarrheal illness was significantly reduced by 32 percent in the group given Lactobacillus reuteri Protectis compared with placebo. In children with low nutritional status (height and below average weight for age group) Lactobacillus reuteri Protectis produce a significant effect of the WHO and the whole explanation of diarrheal diseases.
None of the other interventions showed significant effects of the explanation of the WHO or the whole of diarrhea and there is no intervention that affects the incidence or duration of acute respiratory tract infections. An additional finding can significantly reduce the use of antibiotics in Lactobacillus reuteri Protectis given to children as compared with those receiving placebo.
The study was conducted independently of BioGaia [http://www.biogaia.com] and the results were announced in a press release by NIZO food research at the date of February 21, 2012: http://www.nizo.com/news/latest-news/ 56/bovee.
The study will be published in the Journal of Pediatrics. dr Rina Agustina also will announce the results of the International Symposium on Probiotics and Prebiotics in of Pediatrics (IS3P) on February 24, 2012.
- "The results of a new and very positive with Lactobacillus reuteri Protectis previous research suggests the type of probiotics in children with acute diarrhea. As with other types of probiotics tested in this study showed no positive effect, it reinforces the importance of using the right type when choosing a probiotic , "said Peter Rothschild, President BioGaia. (source: antaranews.com)
The design of the study
A double-blind placebo-controlled for six months was conducted in Indonesia and included 494 healthy children aged one to six years. These children were randomly assigned to low-lactose milk with or without Lactobacillus casei or Lactobacillus reuteri DSM17938 431.
The main result is the amount and duration of acute diarrheal disease. Diarrhea is measured based on information from the World Health Organization (WHO), is greater than or equal to 3 loose / liquid stools within 24 hours, and as all diarrheal disease, greater than or equal to 2 loose / liquid stools in 24 hours. Secondary outcomes were the number and duration of acute respiratory infection.
The results were significant only with Lactobacillus reuteri Protectis
The results showed that the incidence of all diarrheal illness was significantly reduced by 32 percent in the group given Lactobacillus reuteri Protectis compared with placebo. In children with low nutritional status (height and below average weight for age group) Lactobacillus reuteri Protectis produce a significant effect of the WHO and the whole explanation of diarrheal diseases.
None of the other interventions showed significant effects of the explanation of the WHO or the whole of diarrhea and there is no intervention that affects the incidence or duration of acute respiratory tract infections. An additional finding can significantly reduce the use of antibiotics in Lactobacillus reuteri Protectis given to children as compared with those receiving placebo.
The study was conducted independently of BioGaia [http://www.biogaia.com] and the results were announced in a press release by NIZO food research at the date of February 21, 2012: http://www.nizo.com/news/latest-news/ 56/bovee.
The study will be published in the Journal of Pediatrics. dr Rina Agustina also will announce the results of the International Symposium on Probiotics and Prebiotics in of Pediatrics (IS3P) on February 24, 2012.
- "The results of a new and very positive with Lactobacillus reuteri Protectis previous research suggests the type of probiotics in children with acute diarrhea. As with other types of probiotics tested in this study showed no positive effect, it reinforces the importance of using the right type when choosing a probiotic , "said Peter Rothschild, President BioGaia. (source: antaranews.com)
0 komentar:
Post a Comment